things I've learnt over the last 14 months, page-7

First 7 Last

Share
Profile

Follow
AlbertE

4,579 Posts.

695

17/05/17

11:55

Post #: 24740199
Share

Originally posted by DerekT ↑

I've just old my final mesoblast shares in the last few weeks, having only held for around 14 months. Have made a 35% profit in that time, and I'm glad I'm out. Here's why:

1) There is something very unprofessional about the corporate updates and other communication this company provides. I'm not sure if it reflect dodginess or incompetence, but I'm not comfortable with them having my money
2) this company essentially has 1 product. They then package and brand this single product under multiple names and have somehow convinced some people that they have cures to multiple previously incurable diseases. Does this seem likely? Also, the TGA has just spoken its mind on the re-packaging of a single drug for multiple individual diseases (Ibuprofen).
3) Stem cells were supposed to be used to grow new tissue (e.g. for damaged hearts, damaged spinal cords). This hasn't happened. And it looks to me like stem cell companies are having to find uses for their very expensive products by testing them against every incurable disease out there. I am a doctor (in an unrelated field), but I did attend a half-day session on stem cells last year at a North American conference, and all the researchers there thought that clinical applications are at least a decade away. Of note and relevance to mesoblast, they used the GVHD product as an example of a failed drug (and failed company), and a paediatric cardiac surgeon from Boston presented on using stem cells for congenital heart disease and basically just present a series of negative studies. He was not optimistic. I don't think MSB is going to be curing any previously incurable diseases anytime soon.
4) As seen on this message board, people are either believers or non-believers, and tend to have very strong feelings either way. This doesn't happen for companies whose science is solid (e.g. CSL).
5) Financing and capital raising - the way this companies deals with investment banks and stock brokers is amateur, even by Australian standard. They have been taken for a ride, and there is no reason to think it won't happen again.

If I was interested in trading, I can see how it is possible to make money out of this company. I generally hold for the long term, and this company is not for me.

I'll continue to follow with interest. Good luck.

Expand

Why the lengthy exposition. Who cares why you sold and are glad you are out? It appears you are risk averse and this company is not for you.

Good luck being out. Meanwhile this drop in price which has prompted you to sell, has provided myself an opportunity to buy more at lower prices.

This company has the potential (so far progress has been positive) to change the face of healthcare/medicine moving into the future. And for the betterment of us all. Is it without risk - Obviously not, we are not naive - but a worthy cause I am willing to put my hard earned on.

MSB Price at posting: $2.33 Sentiment: Buy Disclosure: Held
15 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

LU7

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Failure to report prompts ASX to impose multiple company suspensions

IRE

Iress runs 'hot' for Wealth Within's stock tips

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 19 more messages in this thread...

First 7 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.21		Change 0.040(3.42%)		Mkt cap ! $1.381B

Open	High	Low	Value	Volume
$1.17	$1.22	$1.17	$5.683M	4.776M

Buyers (Bids)

No.	Vol.	Price($)
1	20000	$1.21

Sellers (Offers)

Price($)	Vol.	No.
$1.21	19746	3

View Market Depth

No.	Vol.	Price($)
1	20000	1.205
2	55500	1.200
3	60292	1.195
1	33180	1.190
3	67965	1.185

Price($)	Vol.	No.
1.210	19746	3
1.215	45236	7
1.220	190559	15
1.225	70181	4
1.230	169274	5

Last trade - 16.10pm 01/10/2024 (20 minute delay)

MSB (ASX) Chart

things I've learnt over the last 14 months, page-7

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Failure to report prompts ASX to impose multiple company suspensions

Iress runs 'hot' for Wealth Within's stock tips

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

things I've learnt over the last 14 months, page-7

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Failure to report prompts ASX to impose multiple company suspensions

Iress runs 'hot' for Wealth Within's stock tips

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News